Prof Marianne Brodmann (Medical University of Graz, Graz, AT) discusses the IN.PACT Global Study 150mm cohort outcomes from the last 3 years.
This study examined the safety and efficacy of the IN.PACT Admiral™ Drug Eluting Balloon (DEB) in the treatment of atherosclerotic disease in the superficial femoral and/or popliteal arteries.
1. What was the IN.PACT global study?
2. Why was this cohort study needed and why look at the 150mm patients?
3. What were your findings?
4. What conclusions can be made from this data?
5. What further research is required?
Filmed on location at the Leipzig Interventional Course 2020.
Interviewer: David Ramsey
Videographer: Natascha Wienand